[MDGL] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
28-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -24.83%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -373,630 -295,350 -241,846 -202,244 -83,948 -32,811 -31,154 51.26%
Tax 0 3,964 -768 -4,800 -11,136 7,871 -635 -
NP -373,630 -299,314 -241,078 -197,444 -72,812 -32,811 -31,154 51.26%
Tax Rate - - - - - - - -
Total Cost 373,630 299,314 241,078 197,444 72,812 32,811 31,154 51.26%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -19.99 -17.47 -14.58 -12.78 -4.73 -2.22 -2.54 41.01%
EPS Diluted -19.99 -17.47 -14.58 -12.78 -4.73 -2.22 -2.54 41.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.